Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes Publisher Pubmed

Shojaei S^{1, 2, 3, 4} ; Koleini N^{5, 6} ; Samiei E^{2, 3, 4} ; Aghaei M^{1, 7} ; Cole LK⁸ ; Alizadeh J¹ ; Islam MI⁹ ; Vosoughi AR¹ ; Albokashy M¹ ; Butterfield Y^{10, 11} ; Marzban H¹ ; Xu F⁸ ; Thliveris J¹ ; Kardami E^{1, 5} Show All Authors

Shojaei S^{1, 2, 3, 4}
Koleini N^{5, 6}
Samiei E^{2, 3, 4}
Aghaei M^{1, 7}
Cole LK⁸
Alizadeh J¹
Islam MI⁹
Vosoughi AR¹
Albokashy M¹
Butterfield Y^{10, 11}
Marzban H¹
Xu F⁸
Thliveris J¹
Kardami E^{1, 5}
Hatch GM⁸
Eftekharpour E⁹
Akbari M^{2, 3, 4}
Hombachklonisch S¹
Klonisch T^{1, 12}
Ghavami S^{1, 12, 13, 14}

Show Affiliations

1. Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
2. Laboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, University of Victoria, Canada
3. Center for Biomedical Research, University of Victoria, Canada
4. Center for Advanced Materials and Related Technology (CAMTEC), University of Victoria, Canada
5. Institute of Cardiovascular Sciences, St-Boniface Hospital Albrechtsen Research Centre Winnipeg, Canada
6. Department of Physiology and Pathophysiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
7. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
8. Department of Pharmacology & Therapeutics, Center for Research and Treatment of Atherosclerosis, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
9. Regenerative Medicine Program, Spinal Cord Research Centre, Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg, Canada
10. Genome Sciences Centre, BC Cancer, Vancouver, Canada
11. Patient Advocate and Research Committee, Brain Tumour Foundation of Canada, Ottawa, Canada
12. Research Institute in Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada
13. Biology of Breathing, Children Hospital Research Institute of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, Winnipeg, Canada
14. Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Iran

Source: FEBS Journal Published:2020

Abstract

Temozolomide (TMZ) is a chemotherapy agent used to treat Grade IV astrocytoma, also known as glioblastoma (GBM). TMZ treatment causes DNA damage that results in tumor cell apoptosis and increases the survival rate of GBM patients. However, chemoresistance as a result of TMZ-induced autophagy significantly reduces this anticancer effects over time. Statins are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme of the mevalonate (MEV) cascade. Statins are best known for their cholesterol (CH)-lowering effect. Long-term consumption of statins, prior to and in parallel with other cancer therapeutic approaches, has been reported to increase the survival rate of patients with various forms of cancers. In this study, we investigated the potentiation of TMZ-induced apoptosis by simvastatin (Simva) in human GBM cell lines and patient GBM cells, using cell monolayers and three-dimensional cell culture systems. The incubation of cells with a combination of Simva and TMZ resulted in a significant increase in apoptotic cells compared to cells treated with TMZ alone. Incubation of cells with CH or MEV cascade intermediates failed to compensate the decrease in cell viability induced by the combined Simva and TMZ treatment. Simva treatment inhibited the autophagy flux induced by TMZ by blocking autophago-lysosome formation. Our results suggest that Simva sensitizes GBM cells to TMZ-induced cell death in a MEV cascade-independent manner and identifies the inhibition of autophagosome-lysosome fusion as a promising therapeutic strategy in the treatment of GBM. © 2019 Federation of European Biochemical Societies

Related Docs

View other Related Docs

1. Statins: A New Approach to Combat Temozolomide Chemoresistance in Glioblastoma, Journal of Investigative Medicine (2018)

2. Mechanisms of Simvastatin Myotoxicity: The Role of Autophagy Flux Inhibition, European Journal of Pharmacology (2019)

3. Glioblastoma and Chemoresistance to Alkylating Agents: Involvement of Apoptosis, Autophagy, and Unfolded Protein Response, Pharmacology and Therapeutics (2018)

4. Could Drugs Inhibiting the Mevalonate Pathway Also Target Cancer Stem Cells?, Drug Resistance Updates (2016)

5. Targeting Cholesterol Metabolism in Glioblastoma: A New Therapeutic Approach in Cancer Therapy, Journal of Investigative Medicine (2019)

6. Detection of Small Gtpase Prenylation and Gtp Binding Using Membrane Fractionation and Gtpase-Linked Immunosorbent Assay, Journal of Visualized Experiments (2018)

7. Atorvastatin Enhances Anti-Apoptotic Effects of Tamoxifen on Melanoma Cancer Cells, Bratislava Medical Journal (2019)

8. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)

Experts (# of related papers)

View all Related Experts

Shaghayegh Haghjooy Javanmard (5)

Mahmoud Aghaei (4)

Other Related Docs

9. The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in Covid-19 Patients With Diabetes Mellitus: A Longitudinal Multicenter Study, Archivum Immunologiae et Therapiae Experimentalis (2023)

10. The Er Stress/Upr Axis in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis, Life (2021)

11. Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies, Molecular Cancer (2025)

12. Unfolded Protein Response Signaling in Hepatic Stem Cell Activation in Liver Fibrosis, Current Protein and Peptide Science (2024)

13. Targeting Autophagy, Oxidative Stress, and Er Stress for Neurodegenerative Disease Treatment, Journal of Controlled Release (2022)

14. Targeting Glioma Cells With Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives, Mini-Reviews in Medicinal Chemistry (2023)

15. The Role of Bip and the Ire1α–Xbp1 Axis in Rhabdomyosarcoma Pathology, Cancers (2021)

16. Evaluation of O6-Methylguanine-Dna Methyltransferase Enzyme Expression Effect on Survival of Patients With Grade 4 Brain Astrocytoma, Journal of Research in Medical Sciences (2014)

17. Resveratrol As an Antitumor Agent for Glioblastoma Multiforme: Targeting Resistance and Promoting Apoptotic Cell Deaths, Acta Histochemica (2023)

18. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application, Current Molecular Pharmacology (2016)

19. Nrf-Mediated Autophagy and Upr: Exploring New Avenues to Overcome Cancer Chemo-Resistance, European Journal of Pharmacology (2025)

20. Sar131675 Receptor Tyrosine Kinase Inhibitor Induces Apoptosis Through Bcl-2/Bax/Cyto C Mitochondrial Pathway in Human Umbilical Vein Endothelial Cells, Anti-Cancer Agents in Medicinal Chemistry (2022)

21. Investigation the Effect of Adenosine A1 Receptor Agonist and Antagonist on P53 Gene Expression, and Apoptosis Pathways and Rate in U87mg Multiform Glioblastoma, Journal of Isfahan Medical School (2021)

22. Temozolomide and Tranilast Synergistic Antiproliferative Effect on Human Glioblastoma Multiforme Cell Line (U87mg), Medical Journal of the Islamic Republic of Iran (2019)

23. Toxicity of Atorvastatin on Pancreas Mitochondria: A Justification for Increased Risk of Diabetes Mellitus, Basic and Clinical Pharmacology and Toxicology (2017)

24. Joint Application of Biochemical Markers and Imaging Techniques in the Accurate and Early Detection of Glioblastoma, Pathology Research and Practice (2021)

25. Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia, Current Nanoscience (2012)

26. Formononetin and Dihydroartemisinin Act Synergistically to Induce Apoptosis in Human Acute Myeloid Leukemia Cell Lines, Cell Journal (2024)

27. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies, Journal of Pharmacy and Pharmaceutical Sciences (2016)

28. The Effect of Pioglitazone on the Alzheimer’S Disease-Induced Apoptosis in Human Umbilical Vein Endothelial Cells, International Journal of Preventive Medicine (2013)

29. The Tangled Web of Dyslipidemia and Cancer: Is There Any Association?, Journal of Research in Medical Sciences (2022)

30. Evaluation of Hydro-Alcoholic Extract of Trifolium Pratens L. for Its Anti-Cancer Potential on U87mg Cell Line, Cell Journal (2018)

31. Highlighting Roles of Autophagy in Human Diseases: A Perspective From Single-Cell Rna Sequencing Analyses, Drug Discovery Today (2024)

32. Lovastatin Prevents Bleomycin-Induced Dna Damage to Hepg2 Cells, Research in Pharmaceutical Sciences (2016)

33. Atorvastatin Enhances the Antitumor Activity of Tamoxifen in B16f10 Mouse Melanoma Cell Lines, Physiology and Pharmacology (Iran) (2021)

34. The Cytotoxicity of 27-Hydroxycholesterol in Mcf-7 and Mda-Mb-231, Advanced Biomedical Research (2023)

35. Investigation of Serum Levels and Tissue Expression of Two Genes Igfbp-2 and Igfbp-3 Act As Potential Biomarker for Predicting the Progression and Survival in Patients With Glioblastoma Multiforme, Journal of the Neurological Sciences (2016)

36. Design, Synthesis, and Biological Evaluation of Novel Atorvastatin Derivatives, Journal of Molecular Structure (2023)

37. Modulating Wnt/Β-Catenin Signaling Pathway on U251 and T98g Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, a Molecular Docking Simulations and Gene Expression Study, Chemical and Pharmaceutical Bulletin (2023)

38. Resveratrol Inhibits Glioblastoma Cells and Chemoresistance Progression Through Blockade P-Glycoprotein and Targeting Akt/Pten Signaling Pathway, Chemico-Biological Interactions (2023)

39. The Antagonistic Atorvastatin-Glibenclamide Interactions Suppressed the Atorvastatin-Induced Bax/Cytochrome C/P53 Mrna Expressions and Increased Rho a Mrna Expression in B16f10 Melanoma Cell Culture, Gene Reports (2021)

40. Epigenetic Regulation of Autophagy in Gastrointestinal Cancers, Biochimica et Biophysica Acta - Molecular Basis of Disease (2022)

41. The Effects of Sterol-Related Signaling Pathways on Glioma, Nutrition and Cancer (2022)

42. The Role of Natural Products As Inhibitors of Jak/Stat Signaling Pathways in Glioblastoma Treatment, Oxidative Medicine and Cellular Longevity (2022)

Style	Citing Format
MLA	Shojaei S, et al.. "Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes." FEBS Journal, vol. 287, no. 5, 2020, pp. 1005-1034.
APA	Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, Vosoughi AR, Albokashy M, Butterfield Y, Marzban H, Xu F, Thliveris J, Kardami E, Hatch GM, Eftekharpour E, Akbari M, Hombachklonisch S, Klonisch T, Ghavami S (2020). Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes. FEBS Journal, 287(5), 1005-1034.
Chicago	Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, Islam MI, et al.. "Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes." FEBS Journal 287, no. 5 (2020): 1005-1034.
Harvard	Shojaei S et al. (2020) 'Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes', FEBS Journal, 287(5), pp. 1005-1034.
Vancouver	Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J, et al.. Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes. FEBS Journal. 2020;287(5):1005-1034.
BibTex	@article{ author = {Shojaei S and Koleini N and Samiei E and Aghaei M and Cole LK and Alizadeh J and Islam MI and Vosoughi AR and Albokashy M and Butterfield Y and Marzban H and Xu F and Thliveris J and Kardami E and Hatch GM and Eftekharpour E and Akbari M and Hombachklonisch S and Klonisch T and Ghavami S}, title = {Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes}, journal = {FEBS Journal}, volume = {287}, number = {5}, pages = {1005-1034}, year = {2020} }
RIS	TY - JOUR AU - Shojaei S AU - Koleini N AU - Samiei E AU - Aghaei M AU - Cole LK AU - Alizadeh J AU - Islam MI AU - Vosoughi AR AU - Albokashy M AU - Butterfield Y AU - Marzban H AU - Xu F AU - Thliveris J AU - Kardami E AU - Hatch GM AU - Eftekharpour E AU - Akbari M AU - Hombachklonisch S AU - Klonisch T AU - Ghavami S TI - Simvastatin Increases Temozolomide-Induced Cell Death by Targeting the Fusion of Autophagosomes and Lysosomes JO - FEBS Journal VL - 287 IS - 5 SP - 1005 EP - 1034 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract